ANDOVER, Mass., Oct. 15, 2015 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) today announced the new tools and services for integrated imaging and treatment planning for radiation oncology that will be highlighted at ASTRO's 57th Annual Meeting in San Antonio on Oct. 18 through Oct. 21. This new portfolio is designed to help clinicians treat cancer with the efficiency and accuracy needed for confident cancer care.
"Philips has a rich history of innovations that redefine how personalized care is delivered. Our commitment to provide integrated solutions in radiation oncology helps to put more control in the hands of the clinician, with the intent to improve workflow, procedure accuracy and ultimately patient care," said Rob Cascella, CEO Imaging Business Groups, Philips.
The Philips booth (#1350) at ASTRO 2015 will showcase the company's growing contributions to radiation oncology with a suite of new and updated solutions to help clinicians make informed decisions to enhance the quality of cancer care.
At ASTRO, Philips will unveil O-MAR2 metal artifact reduction for magnetic resonance imaging (MRI), which can improve visualization of more tissue in the near vicinity of MR conditional orthopedic implants(1). Higher quality imaging is increasingly important as it allows a more detailed look at the affected area, which leads to better treatment. Philips will also announce that its MR-only simulation (2) is 510(k) pending, an upgrade to the Ingenia MR-RT platform intended to provide electron density and anatomical information for prostate dose calculations quickly and efficiently in one MR imaging session.
Philips will also highlight the following key product updates at the event:
- Pinnacle³ 14 with Tumor LOC v4.2 – Enhanced with a new user interface and patient marking workflow, Pinnacle3 14 with Tumor LOC v4.2, combines tools for patient marking with Computed Tomography (CT) simulation to increase clinician productivity.
- iPatient Platform – Upgraded to include new, patient-specific methods to facilitate optimal(3) management of both image quality and radiation dose, iPatient automatically reduces scan times in some cases up to 24%(4), increases clinician confidence and improves image consistency from scan to scan.
- Ingenia MR-RT –Upgraded with an integrated, thin couch top and easy to use coil support for positioning freedom and enhanced imaging quality, Ingenia MR-RT provides soft tissue contrast to help clinicians view targets and organs at risk, allowing them to design the best possible treatment plans. The demonstration will include a dedicated head and neck coil solution for RT imaging for treatment planning, and a ready-to-use geometric quality assurance package for easy monitoring of the system's performance.
For more information on Philips' presence at ASTRO, including the full suite of Philips radiation oncology technology and solutions, please visit: http://www.usa.philips.com/healthcare/about/events-calendar/astro-2015.
Philips' radiation oncology solutions will also be showcased in booth #6736 at the upcoming Radiological Society of North America Annual Meeting, Nov. 29 - Dec. 4, in Chicago, Ill. Follow @PhilipsLiveFrom or visit www.philips.com/rsna for more information on Philips' presence at #RSNA15.
For further information, please contact:
Tel: + 1 781-277-1170
Tel: +1 978-221-8919
Email: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
(1) Only for use with MR Safe or MR Conditional Implants by strictly following the Instructions For Use.
(2) 510(k) pending and not available in the U.S.
(3) "Optimal" refers to the use of strategies and techniques that facilitate the management and control of both image quality and dose.
(4) In a study done using multiphasic liver CT exams the iPatient software platform reduced time-to-results by 24% and clicks per exam by 66%. Impact of workflow tools in reducing total exam and user interaction time - 4 phase liver computed tomography exams. Nicholas Ardley - Southern Health, Kevin Buchan - Philips Healthcare, Ekta Dharaiya - Philips Healthcare.
SOURCE Royal Philips